Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

17.93
Delayed Data
As of May 26
 -1.21 / -6.32%
Today’s Change
7.84
Today|||52-Week Range
37.69
+1.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.001.0K
 
 
Depreciation And Amortization30.0K50.0K1.0K5.0K
 
 
 
 
 
 
Operating ExpensesGross Income-30.0K-50.0K-1.0K--
 
 
 
 
General Expenses3.2M6.0M3.1M6.0M
 
 
 
 
 
Other Operating Expenses0.000.000.0074.0K
 
 
Research And Development1.6M2.1M64.0K2.8M
 
 
 
 
 
Total Operating Expenses3.2M6.1M3.1M6.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.2M-6.1M-3.1M-6.1M
 
 
 
 
 
Extraordinary Credit2.0K--0.000.00
 
 
Extraordinary Charge0.00-3.0K-4.0K0.00
 
 
 
Interest Expense On Debt0.000.000.00249.0K
 
 
Other Expenses0.000.000.00-325.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.2M-5.9M-3.1M-6.7M
 
 
 
 
 
Income Taxes-8.0K-8.0K-3.0K0.00
 
 
 
 
Net Income-3.2M-5.9M-3.1M-6.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M2.1M2.1M6.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M2.1M2.1M6.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.50-$2.70-$1.50-$1.06
 
 
 
 
 
EPS Diluted-$1.50-$2.70-$1.50-$1.06